Over the years we have refined our hybridoma technology to such an extent that our success rate is nearing 100% for every immunogen. We perform high-throughput experiments which result in multiple clones producing high affinity bio-active mAbs. Several of the monoclonal antibodies developed at our facility are in successful production at grams scale (references available).
We can generate mono- or poly-clonal antibodies against given protein, peptide, hapten or other small molecules requiring bio- conjugation. If you don’t have the antigen ready with you, no problem, you can give us the gene sequence; we will clone it, produce the recombinant protein and generate antibodies against the same.